Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.

Proceedings of the National Academy of Sciences of the United States of America - 19 Aug 2014

Yan Dan, Lee Sujin, Thakkar Vidhi D, Luo Ming, Moore Martin L, Plemper Richard Karl

Abstract excerpt

Respiratory syncytial virus (RSV) is a leading pediatric pathogen that is responsible for a majority of infant hospitalizations due to viral disease. Despite its clinical importance, no vaccine prophylaxis against RSV disease or effective antiviral therapeutic is available. In this study, we established a robust high-throughput drug screening protocol by using a recombinant RSV reporter virus to expand the pool...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cricetinae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Membrane Fusion

Share to Mice, Inbred BALB C

Share to Respiratory Syncytial Viruses

Share to Small Molecule Libraries

Share to Viral Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 25092342
DOI: 10.1073/pnas.1405198111
PMCID: PMC4143008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.PMID 25092342Read ↗

Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.Semantic proximity Read ↗

Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay.Semantic proximity Read ↗

Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.Semantic proximity Read ↗

Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance ProfilesSemantic proximity Read ↗

Orally active fusion inhibitor of respiratory syncytial virus.Semantic proximity Read ↗

Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.Semantic proximity Read ↗

Structure-guided design of small-molecule therapeutics against RSV diseaseSemantic proximity Read ↗

Structural Insight into Paramyxovirus and Pneumovirus Entry InhibitionSemantic proximity Read ↗

Functional implications of respiratory syncytial virus F sequence variability: a comparative analysis using contemporary RSV isolatesSemantic proximity Read ↗

Respiratory syncytial virus entry mechanism in host cells: A general overviewSemantic proximity Read ↗

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read ↗

Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.